Post by The Francis Crick Institute

Congratulations to the GSK-Crick Prosperity Partnership, who recently won two prizes – a Horizon Prize from the Royal Society of Chemistry, and the Innovation Enabled by Partnership award from the Society of Chemical Industry. The partnership, established in 2021 with funding from GSK and the Engineering and Physical Sciences Research Council (EPSRC) , includes dedicated scientists from both the Crick and GSK working towards discovering new drug targets. Their goal was to develop and industrialise reactive fragment screening technologies, to simultaneously identify drug targets and prototype molecules, which can control the function of target proteins in cells. Since then, the team have brought together cutting-edge functional genomics, machine learning and next generation chemistry to build a scalable platform to test the interactions of thousands of proteins and potential drug molecules in live cells at once. Read more: https://lnkd.in/etRtG85W